340B Health

340B Insight Podcast

340B Insight

340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.

Listen and Subscribe

Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org

Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org

Follow 340B Health on Twitter, Facebook, and LinkedIn

 


Episodes

  • BONUS EPISODE: Taking the 340B Case to Court

    This week we have a breaking news bonus episode of 340B Insight. 340B Health President and CEO Maureen Testoni joins us to discuss the filing of a lawsuit against the Department of Health & Human Services with four other national hospital organizations, a national pharmacists' organization, and three individual 340B hospitals, seeking to halt drug companies’ refusals to provide 340B discounts to hospitals on covered drugs dispensed at community-based contract pharmacies. (Transcript)

    Read more

  • Episode 15: Responding to COVID-19’s Resurgence

    This week we are joined by Danielle Sestito, system director for the 340B program at Northwell Health in New York. Northwell Health is New York’s largest health system and was one of the systems most affected by the initial COVID-19 outbreak last spring. Danielle shares how Northwell responded to the initial outbreak and how it has prepared for a resurgence. She also discusses how the health system has avoided drug shortages while maintaining 340B compliance and the importance of HRSA’s 340B regulatory flexibilities during the public health emergency. Prior to the interview, we share updates on how some of the Trump administration’s final health care actions could affect 340B. (Transcript)

    Read more

    This Episode is Sponsored By

  • The Biden Administration, New Congress, and 340B

    This week, we speak with Rodney Whitlock, former legislative staffer for Republicans on Capitol Hill and Jeremy Sharp, a former Capitol Hill and executive branch staffer for Democrats. Rodney and Jeremy discuss with 340B Health’s Kathryn DiBitetto how the incoming Biden administration and new Congress might affect the 340B program. The conversation also discusses what the congressional lame-duck session before the end of the year will mean for 340B and how hospital advocates should be preparing for the new administration and new Congress. Prior to the interview, we share news updates, including a bipartisan House of Representatives letter to HHS Secretary Alex Azar regarding pharmaceutical company attempts to turn 340B into a rebate program. (Transcript)

    Read more

    This Episode is Sponsored By

  • Celebrating National Rural Health Day

    For this episode of 340B Insight we speak with Alan Morgan, CEO of the National Rural Health Association. Alan previews National Rural Health Day on November 19, discusses how rural hospitals are faring during the COVID-19 pandemic, the future of rural hospitals, the role of 340B to help hospitals stay afloat, and why drug manufacturers attacks on contract pharmacies are detrimental to rural hospitals and their patients. In our news segment prior to the interview, we recap how Novartis has become the fourth drug manufacturer to block 340B discounts when drugs are dispensed at some contract pharmacies. We also celebrate the 340B program’s anniversary. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode Twelve: Advocacy in Action

    In this episode, we speak with Julie Clements, Director of Health and Clinical Affairs at the University of California Office of Federal Government Relations. Clements details why advocating for 340B is critical, how health care professionals can engage in advocacy, and how advocacy has changed during the COVID-19 pandemic. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode Eleven: Researching 340B’s Value to Medication Therapy Management

    In this episode, we spoke with Dr. Jessica Tilton, the clinical coordinator for the University of Illinois Health Medication Therapy Management Clinic and a clinical assistant professor in the Department of Pharmacy Practice at the University of Illinois at Chicago College of Pharmacy. Jessica discusses the research she and her colleagues have conducted that demonstrates how the clinic is measurably improving patient health outcomes. Prior to the interview, we provide news updates on additional drug manufacturers refusing to provide 340B discounts and the Centers for Medicare and Medicaid Services reviewing comment letters regarding its proposals to make deep Medicare Part B cuts in 2021. (Transcript)

    Read more

    This Episode is Sponsored By